Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients

Journal of the American College of Cardiology

Volumn 72, Issue 7, 2018, Pages 707-717

  Bajaj, Navkaranbir S ^a   Osborne, Michael T ^a,b   Gupta, Ankur ^a   Tavakkoli, Ali ^a   Bravo, Paco E ^a   Vita, Tomas ^a   Bibbo, Courtney F ^a   Hainer, Jon ^a   Dorbala, Sharmila ^a   Blankstein, Ron ^a   Bhatt, Deepak L ^a   Di Carli, Marcelo F ^a   Taqueti, Viviany R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

bariatric surgery; body mass index; coronary microvascular dysfunction; obesity; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY MICROVASCULAR DYSFUNCTION; FEMALE; HEART PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; COHORT ANALYSIS; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; FRACTIONAL FLOW RESERVE; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; OBESITY; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS;

EID: 85050651816     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.05.049     Document Type: Article

References (40)

1. Heymsfield, S.B., Wadden, T.A., Mechanisms, pathophysiology, and management of obesity. N Engl J Med 376 (2017), 254–266.
2. Ortega, F.B., Lavie, C.J., Blair, S.N., Obesity and cardiovascular disease. Circ Res 118 (2016), 1752–1770.
3. Stefan, N., Haring, H.U., Hu, F.B., Schulze, M.B., Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1 (2013), 152–162.
4. Kim, J., Eisenberg, D., Azagury, D., Rogers, A., Campos, G.M., American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis 12 (2016), 453–459.
5. Schauer, P.R., Kashyap, S.R., Wolski, K., et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366 (2012), 1567–1576.
6. Pareek, M., Schauer, P.R., Kaplan, L.M., Leiter, L.A., Rubino, F., Bhatt, D.L., Metabolic surgery: weight loss, diabetes, and beyond. J Am Coll Cardiol 71 (2018), 670–687.
7. Taqueti, V.R., Myocardial perfusion imaging in extreme obesity: leveraging modern technologies to meet a modern challenge. J Nucl Cardiol, 2017 Jun 19 [E-pub ahead of print].
8. Motivala, A.A., Rose, P.A., Kim, H.M., et al. Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women. J Nucl Cardiol 15 (2008), 510–517.
9. Schindler, T.H., Cardenas, J., Prior, J.O., et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 47 (2006), 1188–1195.
10. Tona, F., Serra, R., Di Ascenzo, L., et al. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis 24 (2014), 447–453.
11. Murthy, V.L., Naya, M., Foster, C.R., et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 124 (2011), 2215–2224.
12. Ziadi, M.C., Dekemp, R.A., Williams, K.A., et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 58 (2011), 740–748.
13. Taqueti, V.R., Hachamovitch, R., Murthy, V.L., et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131 (2015), 19–27.
14. Recio-Mayoral, A., Mason, J.C., Kaski, J.C., Rubens, M.B., Harari, O.A., Camici, P.G., Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J 30 (2009), 1837–1843.
15. Taqueti, V.R., Ridker, P.M., Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X. J Am Coll Cardiol Img 6 (2013), 668–671.
16. Taqueti, V.R., Everett, B.M., Murthy, V.L., et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 131 (2015), 528–535.
17. Taqueti, V.R., Solomon, S.D., Shah, A.M., et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 39 (2018), 840–849.
18. Murthy, V.L., Naya, M., Foster, C.R., et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 126 (2012), 1858–1868.
19. Mechanick, J.I., Youdim, A., Jones, D.B., et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity 21 Suppl 1 (2013), S1–S27.
20. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
21. El Fakhri, G., Kardan, A., Sitek, A., et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med 50 (2009), 1062–1071.
22. Cerqueira, M.D., Weissman, N.J., Dilsizian, V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18 (2002), 539–542.
23. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
24. Gibbons, R.J., Chatterjee, K., Daley, J., et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 33 (1999), 2092–2197.
25. Gould, K.L., Johnson, N.P., Bateman, T.M., et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 62 (2013), 1639–1653.
26. Romero-Corral, A., Somers, V.K., Sierra-Johnson, J., et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32 (2008), 959–966.
27. Sorop, O., Olver, T.D., van de Wouw, J., et al. The microcirculation: a key player in obesity-associated cardiovascular disease. Cardiovasc Res 113 (2017), 1035–1045.
28. Badimon, L., Bugiardini, R., Cenko, E., et al. Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: obesity and heart disease. Eur Heart J 38 (2017), 1951–1958.
29. Quercioli, A., Montecucco, F., Pataky, Z., et al. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. Eur Heart J 34 (2013), 2063–2073.
30. Trask, A.J., Katz, P.S., Kelly, A.P., et al. Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol 113 (2012), 1128–1140.
31. Campbell, D.J., Somaratne, J.B., Prior, D.L., et al. Obesity is associated with lower coronary microvascular density. PLoS One, 8, 2013, e81798.
32. Caleyachetty, R., Thomas, G.N., Toulis, K.A., et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol 70 (2017), 1429–1437.
33. Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 376 (2017), 641–651.
34. Taqueti, V.R., Ridker, P.M., Lipid-lowering and anti-inflammatory benefits of statin therapy: more than meets the plaque. Circ Cardiovasc Imaging, 10, 2017, e006676.
35. Murthy, V.L., Naya, M., Taqueti, V.R., et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 129 (2014), 2518–2527.
36. Taqueti, V.R., Shaw, L.J., Cook, N.R., et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 135 (2017), 566–577.
37. Taqueti, V.R., Dorbala, S., Wolinsky, D., et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol 24 (2017), 1402–1426.
38. Schmaier, A.A., Taqueti, V.R., A lack of reserve: recognizing the large impact of small vessels in the heart. Circulation 138 (2018), 424–428.
39. Chow, B.J., Dorbala, S., Di Carli, M.F., et al. Prognostic value of PET myocardial perfusion imaging in obese patients. J Am Coll Cardiol Img 7 (2014), 278–287.
40. Harnett, D.T., Hazra, S., Maze, R., et al. Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity. J Nucl Cardiol, 2017 Mar 29 [E-pub ahead of print].